Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Ralinepag for pulmonary arterial hypertension has completed; the update covers the study status and its efficacy and safety assessmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases
• Familial Primary Pulmonary Hypertension
• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Ralinepag (ralinepag)

Snippet

Sponsor: United Therapeutics | Conditions: PAH, Pulmonary Hypertension | Phase 3 | Status: COMPLETED